It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
COVID-19 Rapid Evidence Reviews
Toggle navigation
New Search
SK Repository
About
Help
Your Cart:
0
items
Refine Search
Refine Search
Revise search
Search
Document Type
Apply
Evidence Search Report
3
Rapid Review
2
Table
1
Research Team
Apply
EOC
3
Infectious Disease
1
Public Health
2
Status
Apply
3. Completed
6
Category
Apply
Clinical Management
Epidemiology
1
Healthcare Services
5
Infection Prevention and Control
Subject
Apply
Clinical Presentation
1
Comorbidities
3
Health Planning
2
Immunity
1
Infection Prevention and Control
1
Risk
4
Vaccination
5
Vaccines
4
Vulnerable Populations
2
Population
Apply
Aged (80+)
4
All
33
All Pediatrics
14
All adults
12
Homeless
2
Indigenous Peoples
2
Infants
2
Mental Health patients
2
Neonates
2
Other
travelers, migrants, immigrants, internationals
1
vulnerable populations
2
More
Clinical Setting
Apply
Cardiac unit
3
Community
5
Dialysis unit
3
ICU
3
Long Term Care
7
Medicine Unit
3
NICU
3
Oncology
3
Other
2
Primary care
3
Public Health
all clinical (and non) settings
2
More
Advanced Search
All Records
Public Health
Clinical Management
Infection Prevention and Control
Other
Sorted by
Oldest
Sort by Relevance
Sort by Research Question / Title
Sort by Newest
Table View
List View
Citation View
Expand all
Collapse all
Select All
6 records – page 1 of 1.
Prev
Next
Date
Research Question / Title
Unique ID
Research Team
March 4, 2021
What are the vaccination strategies for vulnerable populations?
PH030401-01 ESR
Public Health
March 12, 2021
What are the vaccination strategies for vulnerable populations?
PH030401 RR
Public Health
April 1, 2021
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
EOC210302 ESR
EOC
April 21, 2021
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
EOC210302 RR
EOC
April 21, 2021
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
EOC210302 RR Table
EOC
July 16, 2021
What is known about safety/efficacy of global vaccines not approved in Canada? What are the impacts on international travel and vaccination policies?
INF210701 ESR
Infectious Disease
6 records – page 1 of 1.
Prev
Next